SCHEMBL6612426

SCHEMBL6612426

O=C1Nc2ccc(Cl)cc2/C1=C/Nc1ccc(NCCCN2CCOCC2)cc1.O=C1Nc2ccc(F)cc2/C1=C/Nc1ccc(NCCCN2CCOCC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 4/20 0.51
LRRK2 Q5S007 4/20 0.51
PSEN1 P49768 1/20 0.51
PSEN2 P49810 1/20 0.51
APH1B Q8WW43 1/20 0.51
NCSTN Q92542 1/20 0.51
APH1A Q96BI3 1/20 0.51
PSENEN Q9NZ42 1/20 0.51
PAK1 Q13153 5/20 0.49
PDGFRB P09619 5/20 0.49
KDR P35968 5/20 0.49
FGFR1 P11362 1/20 0.49
KIT P10721 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6612429 1.00 FLT3 (0.51) FLT3LRRK2PSEN1PSEN2APH1B
SCHEMBL4987470 0.96 PDGFRB (0.52) FLT3LRRK2PSEN1PSEN2APH1B
SCHEMBL4987480 0.96 PDGFRB (0.52) FLT3LRRK2PSEN1PSEN2APH1B
SCHEMBL4988383 0.96 LRRK2 (0.54) FLT3LRRK2PSEN1PSEN2APH1B
SCHEMBL4988378 0.96 LRRK2 (0.54) FLT3LRRK2PSEN1PSEN2APH1B
SCHEMBL4991696 0.90 PDGFRB (0.56) FLT3LRRK2PSEN1PSEN2APH1B
SCHEMBL4991684 0.90 PDGFRB (0.56) FLT3LRRK2PSEN1PSEN2APH1B
SCHEMBL4994017 0.90 LRRK2 (0.56) FLT3LRRK2PSEN1PSEN2APH1B
SCHEMBL4994014 0.90 LRRK2 (0.56) FLT3LRRK2PSEN1PSEN2APH1B
SCHEMBL4991096 0.88 PDGFRB (0.44) FLT3PAK1PDGFRBKDRFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1430048-A1 3-(ARYLAMINO)METHYLENE-1, 3-DIHYDRO-2H-INDOL-2-ONES AS KINASE INHIBITORS Allergan, Inc. (US) 2004-06-23 EP disclosed
WO-2003027102-A1 3-(ARYLAMINO)METHYLENE-1, 3-DIHYDRO-2H-INDOL-2-ONES AS KINASE INHIBITORS ALLERGAN, INC. (US) 2003-04-03 WO disclosed